1-113073426-G-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_014813.3(LRIG2):āc.20G>Cā(p.Gly7Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014813.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRIG2 | NM_014813.3 | c.20G>C | p.Gly7Ala | missense_variant | 1/18 | ENST00000361127.6 | |
LRIG2 | XM_005271369.3 | c.20G>C | p.Gly7Ala | missense_variant | 1/17 | ||
LRIG2 | NM_001312686.2 | c.-402G>C | 5_prime_UTR_variant | 1/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRIG2 | ENST00000361127.6 | c.20G>C | p.Gly7Ala | missense_variant | 1/18 | 1 | NM_014813.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000482 AC: 121AN: 251212Hom.: 0 AF XY: 0.000457 AC XY: 62AN XY: 135796
GnomAD4 exome AF: 0.000120 AC: 175AN: 1461704Hom.: 0 Cov.: 31 AF XY: 0.000109 AC XY: 79AN XY: 727140
GnomAD4 genome AF: 0.000184 AC: 28AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | The c.20G>C (p.G7A) alteration is located in exon 1 (coding exon 1) of the LRIG2 gene. This alteration results from a G to C substitution at nucleotide position 20, causing the glycine (G) at amino acid position 7 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
LRIG2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 24, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at